Oncolytic virus-mediated tumor radiosensitization in mice through DNA-PKcs-specific shRNA

Translational Cancer Research

Volumn 1, Issue 1, 2012, Pages 6-14

  Kon, Takashi ^a   Zhang, Xiuwu ^a   Huang, Qian ^b   Yang, Zhonghui ^a   Liu, Shanling ^c   Yan, Bin ^a   Li, Fang ^a   Wang, He ^c   Li, Chuan Yuan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Conditionally replicative adenovirus; DNA PKcs; Radiation therapy; ShRNA; Telomerase

Indexed keywords

EID: 84962710315     PISSN: 2218676X     EISSN: 22196803     Source Type: Journal    
DOI: 10.3978/j.issn.2218-676X.2012.05.02     Document Type: Article

References (22)

1. Rodriguez-Bigas MA, Lin EH, Crane CH. Adenocarcinoma of the colon and rectum. In Cancer Medicince 6 (D. W. Kufe, R. E. Pollock, R. R. Weichselbaum, R. C. Bast, T. S. Gansler, J. F. Holland and E. Frei, Eds.), pp. 1635-65. BC Decker Inc, Hamilton. London, 2003.
2. Mundt AJ, Roeske JC, Chung TD, et al. In Cancer Medicine 6 (D. W. Kuff, R. E. Pollock, R. R. Weichselbaum, R. C. Bast, T. S. Gansler, J. F. Holland and E. Frei, Eds.), pp. 585-604. BC Decker Inc, Hamilton. London, 2003.
3. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47.
4. Coleman CN. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers. Semin Oncol 1989;16:169-75.
5. Gu Y, Jin S, Gao Y, Weaver DT, et al. Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc Natl Acad Sci USA 1997;94:8076-81.
6. Taccioli GE, Amatucci AG, Beamish HJ, et al. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity 1998;9:355-66.
7. Kurimasa A, Ouyang H, Dong LJ, et al. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc Natl Acad Sci USA 1999;96:1403-8.
8. Lavin MF, Khanna KK. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxiatelangiectasia. Int J Radiat Biol 1999;75:1201-14.
9. Thompson LH, Brookman KW, Jones NJ, et al. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol Cell Biol 1990;10:6160-71.
10. Paull TT, Gellert M. Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev 1999;13:1276-88.
11. Frank KM, Sekiguchi JM, Seidl KJ, et al. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998;396:173-7.
12. Veuger SJ, Curtin NJ, Richardson CJ, et al. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res 2003;63:6008-15.
13. Shinohara ET, Geng L, Tan J, et al. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Res 2005;65:4987-92.
14. Hardcastle IR, Cockcroft X, Curtin NJ, et al. Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach. J Med Chem 2005;48:7829-46.
15. Svirnovski AI, Serhiyenka TF, Kustanovich AM, et al. ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells. Exp Oncol 2010;32:258-62.
16. Mo Y, Gan Y, Song S, et al. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Cancer Res 2003;63:579-85.
17. Huang Q, Zhang X, Wang H, et al. A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells. Clin Cancer Res 2004;10:1439-45.
18. Peng Y, Zhang Q, Nagasawa H, et al. Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res 2002;62:6400-4.
19. Collis SJ, Swartz MJ, Nelson WG, et al. Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Res 2003;63:1550-4.
20. Huang Q, Hu JK, Lohr F, et al. Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res 2000;60:3435-9.
21. Garn H, Krause H, Enzmann V, et al. An improved MTT assay using the electron-coupling agent menadione. J Immunol Methods 1994;168:253-6.
22. Tsang NM, Nagasawa H, Li C, et al. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene 1995;10:2403-8.